Current developments in xenon research: Importance for anesthesia and intensive care medicine;Aktuelle entwicklungen in der xenonforschung: Stellenwert für die anästhesie und intensivmedizin

Anaesthesist

Volumn 59, Issue 10, 2010, Pages 883-895

  Brucken A ^a   Coburn, M ^a   Rex, S ^a   Rossaint, R ^a   Fries, M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Anesthetics; N methyl D aspartate receptors; Neuroprotective agents; Protective agents; Xenon

Indexed keywords

CARDIOTONIC AGENT; INHALATION ANESTHETIC AGENT; NEUROPROTECTIVE AGENT; XENON;

BRAIN; BRAIN CIRCULATION; DRUG EFFECT; HUMAN; INDUCED HYPOTHERMIA; INHALATION ANESTHESIA; INTENSIVE CARE; KIDNEY DISEASE; METABOLISM; REVIEW;

ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; BRAIN; CARDIOTONIC AGENTS; CEREBROVASCULAR CIRCULATION; HUMANS; HYPOTHERMIA, INDUCED; INTENSIVE CARE; KIDNEY DISEASES; NEUROPROTECTIVE AGENTS; XENON;

EID: 79952278816     PISSN: 00032417     EISSN: 1432055X     Source Type: Journal    
DOI: 10.1007/s00101-010-1787-6     Document Type: Article

References (59)

1. Adolph O, Köster S, Georgieff M et al (2010) Xe¬non-induced changes in CNS sensitization to pain. Neuroimage 49(1):720-730
2. Banks P, Franks NP, Dickinson R (2010) Competi¬tive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuropro-tection against hypoxia-ischemia. Anesthesiology 112(3):614-622
3. Bantel C, Maze M, Trapp S (2010) Noble gas Xenon is a novel adenosine triphosphate-sensitive potas¬sium channel opener. Anesthesiology 112(3):623-630
4. Baumert JH, Hein M, Hecker KE et al (2007) Autonomic cardiac control with xenon anaesthesia in patients at cardiovascular risk. Br J Anaesth 98(6):722-727
5. Baumert JH, Hein M, Gerets C et al (2007) The effect of xenon anesthesia on the size of expe¬rimental myocardial infarction. Anesth Analg 105:1200-1206
6. Baumert JH, Hein M, Hecker KE et al (2008) Xenon or propofol anaesthesia for patients at cardio¬vascular risk in non-cardiac surgery. Br J Anaesth 100(5):605-611
7. Behnke AR, Yarborough OD (1939) Respiratory resistance, oil-water solubility, and mental effects of argon, compared with helium and nitrogen. Am J Physiol 126:409-415
8. Bock M, Klippel K, Nitsche B et al (2000) Rocuroni¬um potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 84:43-47
9. Coburn M, Kunitz O, Baumert J-H et al (2005) Ran¬domized controlled trial of the hemodynamic and recovery effects of xenon and propofol anaesthe-sia. Br J Anaesth 94:198-202
10. Coburn M, Kunitz O, Baumert J-H, Rossaint R (2005) Patients' self-evaluation after 4-12 weeks following xenon or propofol anaesthesia-a com-parison. Eur J Anaesthesiol 22:870-874
11. Coburn M, Baumert JH, Roertgen D et al (2007) Emergence and early cognitive function in the elderly after xenon or desflurane anaesthesia: A double-blinded randomized controlled trial. Br J Anaesth 98:756-762
12. Coburn M, Kunitz O, Apfel CC et al (2008) Incidence of postoperative nausea and emetic episodes after xenon anaesthesia compared with propofol-based anaesthesia. Br J Anaesth 100(6):787-791
13. Coburn M, Maze M, Franks NP (2008) The neuro¬protective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 36:588-595
14. Cullen SC, Gross EG (1951) The anesthetic pro¬perties of xenon in animals and human beings with additional observations on krypton. Science 133:580-582
15. Derwall M, Çizen A, Löwer C et al (2009) Combi¬ning xenon and mild therapeutic hypothermia to reduce neurological sequelae after cardiac arrest. Circulation 120:S642
16. Dickinson R, Peterson BK, Banks P et al (2007) Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anaesthe¬tics xenon and isoflurane: Evidence from molecular modeling and electrophysiology. Anesthesiology 107(5):756-767
17. Dingley J, Tooley J, Porter H, Thoresen M (2006) Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 37:501-506
18. Franks NP, Dickinson R, Sousa SL de et al (1998) How does xenon produce anaesthesia? Nature 396(6709):324
19. Franks NP (2008) General anaesthesia: From mo¬lecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 9(5):370-386
20. Fries M, Weis J, Rossaint R (2006) Is xenon really neuroprotective after cardiac arrest? Anesthesiology 104:211
21. Fries M, Nolte KW, Coburn M et al (2008) Xenon reduces neurohistopathological damage and im¬proves the early neurological deficit after cardiac arrest in pigs. Crit Care Med 36(8):2420-2426
22. Fries M, Coburn M, Nolte KW et al (2009) Early ad¬ministration of Xenon or Isofluran may not impro¬ve functional outcome and cerebral alterations in a porcine model of cardiac arrest. Resuscitation 80(5):584-590
23. Froeba G, Georgieff M, Linder EM et al (2010) Intranasal application of xenon: Describing the pharmacokinetics in experimental animals and the increased pain tolerance within a placebo-con¬trolled experimental human study. Br J Anaesth 104(3):351-358
24. Gruss M, Bushell TJ, Bright DP et al (2004) Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 65(2):443-452
25. Hanss R, Bein B, Turovski et al (2006) The influence of xenon on regulation of the autonomic nervous system in patients at high risk of perioperative car¬diac complications. Br J Anaesth 96:427-436
26. Hein M, Roehl AB, Baumert JH et al (2008) Estab¬lishment of a porcine right ventricular infarction model for cardioprotective actions of xenon and isoflurane. Acta Anaesthesiol Scand 52:1194-1203
27. Heinke W, Schwarzbauer C (2002) In vivo imaging of anaesthetic action in humans: Approaches with positron emission tomography (PET) and function¬al magnetic resonance imaging (fMRI). Br J Anaes¬th 89(1):112-122
28. Homi HM, Yokoo N, Ma D et al (2003) The neuro¬protective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 99:876-881
29. Jellish WS, Brody M, Sawicki K, Slogoff S (2000) Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics. Anesth Analg 91:1250-1255
30. Jungwirth B, Gordan ML, Blobner M et al (2006) Xenon impairs neurocognitive and histologic out¬come after cardiopulmonary bypass combined with cerebral air embolism in rats. Anesthesiology 104:770-776
31. Jungwirth B, Kellermann K, Blobner M et al (2007) Cerebral air emboli differentially alter outcome af¬ter cardiopulmonary bypass in rats compared with normal circulation. Anesthesiology 107:768-775
32. Kunitz O, Baumert J-H, Hecker K et al (2004) Xenon does not prolong neuromuscular block of rocuro¬nium. Anesth Analg 99:1398-1401
33. Kunitz O, Baumert JH, Hecker K et al (2005) Xenon does not modify mivacurium induced neuromus¬cular block. Can J Anaesth 52:940-943
34. Lachmann B, Armbruster S, Schairer W et al (1990) Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet 335:1413-1415
35. Laitio RM, Kaisti KK, Låangsjö JW et al (2007) Ef¬fects of xenon on cerebral blood flow in humans: A positron emission tomography study. Anesthesio¬logy 106(6):1128-1133
36. Laitio RM, Långsjö JW, Aalto S et al (2009) The effects of xenon anesthesia on the relationship between cerebral glucose metabolism and blood flow in healthy subjects: A positron emission tomography study. Anesth Analg 108(2):593-600
37. Lawrence JH, Loomis WF, Tobias CA, Turpin FH (1946) Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. J Physiol 105(3):197-204
38. Lockwood GG, Franks NP, Downie NA et al (2006) Feasibility and safety of delivering xenon to pa¬tients undergoing coronary bypass graft surgery while on cardiopulmonary bypass: Phase I study. Anesthesiology 104:458-465
39. Ma D, Hossain M, Chow A et al (2005) Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 58:182-193
40. Ma D, Lim T, Xu J et al (2009) Xenon preconditio¬ning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 20(4):713-720. Epub 2009 Jan 14
41. Martin JL, Ma D, Hossain M et al (2007) Asynchro¬nous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat. Br J Anaesth 98:236-240
42. Ohara A, Mashimo T, Zhang P et al (1997) A com¬parative study of the antinociceptive action of xenon and nitrous oxide in rats. Anesth Analg 85:931-936
43. Petzelt C, Blom P, Schmehl W et al (2003) Preventi¬on of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci 72:1909-1918
44. Petzelt C, Blom P, Schmehl W et al (2004) Xenon prevents cellular damage in differentiated PC-12 cells exposed to hypoxia. BMC Neurosci 5:55
45. Preckel B, Mullenheim J, Moloschavij A et al (2000) Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 91:1327-1332
46. Preckel B, Weber NC, Sanders RD et al (2006) Mo¬lecular mechanisms transducing the anaesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 105(1):187-197
47. Rex S, Schaefer W, Meyer PH et al (2006) Positron emission tomography study of regional cerebral metabolism during general anesthesia with xenon in humans. Anesthesiology 105:936-943
48. Rex S, Meyer PT, Baumert JH et al (2008) Positron emission tomography study of regional cerebral blood flow and flow-metabolism coupling during general anaesthesia with xenon in humans. Br J Anaesth 100(5):667-675
49. Roehl AB, Goetzenich A, Rossaint R et al (2010) A practical rule for optimal flows for xenon anaes¬thesia in a semi-closed anaesthesia circuit. Eur J Anaesthesiol 27(7):660-665
50. Rossaint R, Reyle-Hahn M, Schulte Am Esch J et al (2003) Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in pati¬ents undergoing elective surgery. Anesthesiology 98:6-13
51. Salmi E, Laitio RM, Aalto S et al (2008) Xenon does not affect gamma-aminobutyric acid type A receptor binding in humans. Anesth Analg 106(1):129-134
52. Seppelt I (2005) Hypothermia does not improve outcome from traumatic brain injury. Crit Care Resusc 7:233-237
53. Schmidt M, Marx T, Papp-Jambor C et al (2002) Effect of xenon on cerebral autoregulation in pigs. Anaesthesia 57(10):960-966
54. Schmidt M, Marx T, Armbruster S et al (2005) Effect of xenon on elevated intracranial pressure as compared with nitrous oxide and total intrave¬nous anesthesia in pigs. Acta Anaesthesiol Scand 49:494-501
55. Schmidt M, Marx T, Gloggl E et al (2005) Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology 102:929-936
56. Suzuki T, Koyama H, Sugimoto M et al (2002) The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytrypta¬mine3 receptors expressed in Xenopus oocytes. Anesthesiology 96(3):699-704
57. Wappler F, Rossaint R, Baumert J et al (2007) Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery. Anesthesiology 106:463-471
58. Watanabe I, Takenoshita M, Sawada T et al (2004) Xenon suppresses nociceptive reflex in newborn rat spinal cord in vitro; comparison with nitrous oxide. Eur J Pharmacol 496:71-76
59. Weber NC, Toma O, Wolter JI et al (2005) The noble gas xenon induces pharmacological pre¬conditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br J Pharmacol 144(1):123-132